Controlled Substances Regulations Amendments

Summary#

This is a proposed set of changes published in the Canada Gazette on June 1, 2024 by the Department of Health. The amendments mainly tighten up and harmonize how words like “narcotic” and “controlled drug” are defined across several rules, and they tweak fees, labels, licence rules and criminal-record checks. Interested people have 60 days to comment; the rules would come into force on the 365th day after they appear in Canada Gazette, Part II if approved.

What it does#

• Uses the wording and definitions from the Controlled Substances Regulations to replace several older definitions (for example, “controlled drug”, “narcotic” and “dealer’s licence”) in other regulations.
• Changes fee rules so they explicitly apply to dealer’s licences related to narcotics or controlled drugs (affects the Fees in Respect of Dealer’s Licences Regulations and the Licensed Dealers for Controlled Drugs and Narcotics (Veterinary Use) Fees Regulations).
• Says some rules do not apply to a narcotic or controlled drug that is for veterinary use only.
• Requires the licence application fee to be paid when the application is submitted.
• Updates the definition of “nurse practitioner” in the Food and Drug Regulations to match the Controlled Substances Regulations.
• Changes labelling rules so that:
  • narcotics must show the symbol “N” on the label, and
  • controlled drugs and targeted substances must show specified symbols or markings (affects what appears on medicine packaging).
• Excludes drugs listed in the Controlled Substances Regulations from certain parts of the Medical Devices Regulations.
• Updates the Precursor Control Regulations to allow either a dealer’s licence under the Controlled Substances Regulations or an exemption under the Controlled Drugs and Substances Act for producers.
• Changes criminal-record documentation requirements for licence applicants and senior people in charge so the record covers the previous 10 years; one related subsection is removed.
• Sets the proposed coming-into-force timing at the 365th day after publication in Canada Gazette, Part II.

Who's affected#

• Drug manufacturers, packagers and labelling contractors who make prescription drugs, narcotics or controlled drugs.
• Companies and people who apply for or hold dealer’s licences under the Controlled Substances Regulations (including those handling precursors).
• Pharmacies, wholesalers and health-care facilities that handle or distribute narcotics, controlled drugs or targeted substances.
• Veterinarians and businesses that handle drugs “for veterinary use only” (because some rules will explicitly not apply to those products).
• Licence applicants and senior staff whose criminal records are checked as part of licensing (the 10-year lookback applies).
• Health Canada and regulatory staff who administer these rules.
• Consumers may notice changes indirectly through different labels on some medicines.

If anything above is unclear in the official text, the proposal itself is the source and stakeholders are invited to comment during the consultation period.

Why it matters#

• The changes aim to make definitions and requirements consistent across multiple federal rules. That reduces confusion for companies that must follow several different regulations.
• Label changes (like the “N” symbol) could make it easier for pharmacists, health workers and patients to identify narcotics and other controlled drugs at a glance.
• Clarifying that some requirements don’t apply to veterinary-only drugs may reduce unnecessary paperwork for animal-health businesses.
• The updated criminal-record timeframe (10 years) and licence-fee timing affect people applying for licences and senior staff at regulated businesses.
• Because this is a proposal, affected groups have 60 days from June 1, 2024 to comment before anything becomes final. The delayed coming-into-force date (the 365th day after Part II publication) would give time to adjust if the regulations are adopted.